Atherectomy Devices Market Size and Forecast
The global atherectomy devices market is expected to witness robust grow at a CAGR of ~10% during the forecast period, supported by the increasing prevalence of cardiovascular diseases, rising incidence of peripheral artery disease (PAD), growing adoption of minimally invasive vascular procedures, and continuous advancements in interventional cardiology technologies. The market is also benefiting from increasing awareness regarding early diagnosis of vascular disorders, expanding healthcare infrastructure, and the growing demand for advanced plaque removal solutions. However, the high cost of atherectomy procedures, limited reimbursement in certain regions, and the need for specialized physician training continue to pose challenges for market expansion.
Atherectomy devices are specialized interventional medical devices designed to remove or modify atherosclerotic plaque from blood vessels, restoring normal blood flow and improving vascular function. Unlike conventional balloon angioplasty, which compresses plaque against the vessel wall, atherectomy physically removes or debulks plaque, making it particularly effective for treating heavily calcified, complex, and long arterial lesions. These devices are widely utilized in peripheral vascular interventions, coronary artery disease treatment, and other endovascular procedures where plaque burden may compromise procedural success.
The increasing preference for minimally invasive interventions has positioned atherectomy devices as valuable tools in modern cardiovascular care. Continuous innovation in catheter design, imaging integration, and plaque removal technologies is improving procedural safety while expanding the clinical applications of atherectomy systems across hospitals, specialty clinics, and ambulatory surgical centers.
Rising Burden of Cardiovascular Diseases Driving Market Growth
The growing prevalence of cardiovascular diseases remains the primary factor fueling demand for atherectomy devices worldwide.
Conditions such as coronary artery disease, peripheral artery disease, carotid artery disease, and chronic limb ischemia continue to increase due to aging populations, unhealthy dietary habits, sedentary lifestyles, smoking, obesity, diabetes, and hypertension. These risk factors contribute to progressive plaque accumulation within blood vessels, restricting blood circulation and increasing the risk of heart attacks, strokes, and limb-threatening complications.
Atherectomy procedures offer physicians an effective solution for removing calcified plaque before balloon angioplasty or stent implantation, improving vessel preparation and enhancing procedural outcomes. By reducing plaque burden, these devices help improve blood flow while lowering the likelihood of incomplete lesion treatment.
Growing awareness regarding early diagnosis and timely intervention has increased the number of patients undergoing minimally invasive vascular procedures, creating sustained demand for advanced plaque modification technologies.
Healthcare providers are increasingly incorporating atherectomy into treatment strategies for complex arterial disease because of its ability to improve long-term vessel patency and support better clinical outcomes.
Technological Advancements Enhancing Clinical Performance
Continuous technological innovation has significantly transformed the atherectomy devices market by improving device precision, safety, and procedural efficiency.
Modern atherectomy systems feature enhanced catheter flexibility, improved navigation capabilities, advanced rotational and orbital technologies, and superior plaque removal efficiency. These improvements enable physicians to treat increasingly complex vascular lesions while minimizing vessel trauma.
One of the most significant technological developments involves the integration of imaging technologies into atherectomy procedures. Image-guided atherectomy systems provide physicians with enhanced visualization of vascular anatomy and plaque morphology, enabling more accurate treatment planning and improved procedural confidence.
Advanced imaging modalities also help clinicians monitor plaque removal in real time, reducing procedural complications while improving treatment precision.
Manufacturers continue investing in innovations that improve device maneuverability, enhance debris management, and reduce the risk of distal embolization during plaque removal. These advancements contribute to safer interventions and improved patient outcomes.
The growing integration of artificial intelligence, digital imaging, and data-driven procedural planning is expected to further strengthen the capabilities of next-generation atherectomy systems.
Growing Preference for Minimally Invasive Procedures Supporting Adoption
Minimally invasive cardiovascular interventions continue gaining widespread acceptance because they offer numerous advantages compared with traditional open surgical procedures.
Atherectomy procedures typically involve smaller incisions, shorter procedure times, reduced blood loss, lower complication rates, shorter hospital stays, and faster patient recovery. These benefits have significantly increased physician and patient preference for endovascular treatment options.
The ability of atherectomy devices to effectively treat heavily calcified lesions that may not respond adequately to balloon angioplasty alone has expanded their utilization across interventional cardiology and vascular surgery.
Hospitals and vascular specialists increasingly perform atherectomy procedures in combination with balloon angioplasty, drug-coated balloons, and stent implantation to optimize vessel preparation and improve long-term treatment success.
The ongoing shift toward less invasive treatment approaches is expected to remain a major driver of market growth throughout the forecast period.
Expansion of Outpatient and Ambulatory Care Creating New Opportunities
The rapid growth of ambulatory surgical centers and outpatient cardiovascular care is creating significant opportunities for the atherectomy devices market.
Healthcare providers increasingly perform minimally invasive vascular procedures in outpatient settings due to reduced hospitalization costs, faster patient discharge, and improved operational efficiency.
Advancements in compact atherectomy systems, improved catheter technologies, and simplified procedural workflows have made outpatient interventions increasingly feasible for appropriately selected patients.
Patients also prefer outpatient treatment because of shorter recovery periods, lower healthcare expenses, and greater convenience. As healthcare systems continue emphasizing value-based care and cost optimization, demand for outpatient-compatible atherectomy technologies is expected to increase substantially.
Manufacturers are responding by developing user-friendly devices that support efficient treatment in ambulatory care environments while maintaining high levels of clinical performance.
Combination Therapies Expanding Clinical Applications
Another important trend within the atherectomy devices market is the increasing use of combination treatment strategies.
Physicians are increasingly utilizing atherectomy prior to drug-coated balloon angioplasty or stent placement to optimize lesion preparation and improve drug delivery effectiveness. Removing calcified plaque before additional interventions enhances vessel expansion while reducing procedural complications.
Clinical evidence supporting combination therapies continues to expand, encouraging broader physician adoption across complex peripheral and coronary interventions.
These integrated treatment approaches are expected to further strengthen the role of atherectomy within comprehensive vascular disease management.
High Costs Continue to Limit Market Penetration
Despite their clinical advantages, atherectomy devices remain associated with relatively high treatment costs.
The procedures require advanced capital equipment, specialized disposable devices, imaging systems, and highly trained interventional specialists. These factors increase the overall cost of treatment compared with conventional angioplasty procedures.
Healthcare facilities operating under budget constraints may hesitate to adopt advanced atherectomy technologies, particularly in low- and middle-income countries where healthcare resources remain limited.
Variations in reimbursement policies across different healthcare systems also influence purchasing decisions and procedural adoption.
Manufacturers continue working to improve production efficiency while expanding clinical evidence demonstrating long-term cost-effectiveness through reduced repeat interventions and improved patient outcomes.
Need for Specialized Training Presents a Challenge
Successful utilization of atherectomy devices requires significant physician expertise and procedural experience.
Managing heavily calcified lesions while minimizing procedural risks demands specialized technical skills acquired through dedicated training and clinical practice. Limited availability of experienced operators may restrict adoption, particularly in developing healthcare markets.
Healthcare organizations and manufacturers are increasingly investing in physician education programs, simulation-based learning, and hands-on clinical training to improve procedural proficiency.
Expanding access to structured educational initiatives will be essential for ensuring consistent clinical outcomes while supporting broader adoption of atherectomy technologies worldwide.
Regional Analysis
North America dominates the global atherectomy devices market due to its advanced healthcare infrastructure, high prevalence of cardiovascular disease, strong reimbursement systems, and widespread adoption of interventional cardiology procedures.
The United States represents the largest national market, supported by high procedure volumes, increasing incidence of peripheral artery disease, early adoption of innovative technologies, and extensive clinical research activities. Hospitals and ambulatory surgical centers throughout the country continue incorporating advanced atherectomy systems into routine vascular interventions.
Europe maintains a significant market share owing to its established healthcare systems, growing elderly population, increasing burden of vascular disease, and continuous technological adoption. Rising emphasis on minimally invasive cardiovascular procedures continues supporting regional market growth.
Asia-Pacific is expected to register the fastest growth during the forecast period.
Rapid urbanization, increasing healthcare expenditure, expanding cardiovascular disease burden, improving healthcare infrastructure, and growing awareness regarding minimally invasive vascular treatments are driving demand across China, India, Japan, South Korea, and Southeast Asia.
Government investments in cardiovascular care, expanding access to specialized healthcare services, and increasing physician training initiatives are expected to further accelerate regional market expansion.
Latin America and the Middle East & Africa are also emerging as promising markets due to improving healthcare infrastructure, increasing prevalence of lifestyle-related diseases, and greater adoption of advanced vascular intervention technologies.
Competitive Landscape
The atherectomy devices market is highly competitive, with leading medical technology companies focusing on product innovation, strategic collaborations, acquisitions, physician training, and geographic expansion. Manufacturers continue investing in next-generation plaque removal systems that enhance procedural safety, improve clinical outcomes, and simplify physician workflow.
Growing emphasis on image-guided interventions, combination therapies, and minimally invasive treatment solutions is expected to drive continuous innovation within the industry. Companies are also strengthening educational programs and clinical partnerships to increase physician confidence and expand adoption across global healthcare markets.
Key Players
- Becton, Dickinson and Company
- Medtronic plc
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- Abbott Laboratories Inc.
- Avinger, Inc.
- AngioDynamics, Inc.
- Rex Medical, L.P.
- BIOTRONIK
- OrbusNeich Medical Group Holdings Limited
Get Report Details: https://meditechinsights.com/atherectomy-devices-market/request-sample/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.